Drivers of Memory Loss Underreport in Mild Cognitive Impairment Due to Alzheimer Versus Vascular Disease

Author:

Briggs Anthony Q.1,Ouedraogo Tall Sakina2,Boza-Calvo Carolina34,Bernard Mark A.1,Bubu Omonigho M.156,Masurkar Arjun V.17

Affiliation:

1. Department of Neurology, Center for Cognitive Neurology

2. Medicine

3. Centro de Investigación en Hematología y Trastornos Afines (CIHATA)

4. Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica

5. Psychiatry

6. Population of Health

7. Neuroscience Institute, NYU Grossman School of Medicine, New York, NY

Abstract

Background: We examined drivers of self and study partner reports of memory loss in mild cognitive impairment (MCI) from Alzheimer (AD-MCI) and vascular disease (Va-MCI). Methods: We performed retrospective cross-sectional analyses of participants with AD-MCI (n=2874) and Va-MCI (n=376) from the National Alzheimer’s Coordinating Center data set. Statistical analysis utilized 2-sided t test or the Fisher exact test. Results: Compared with AD-MCI, Va-MCI subjects (24.5% vs. 19.7%, P=0.031) and study partners (31.4% vs. 21.6%, P<0.0001) were more likely to deny memory loss. Black/African Americans were disproportionately represented in the group denying memory loss in AD-MCI (20.0% vs. 13.2%, P<0.0001) and Va-MCI (33.7% vs. 18.0%, P=0.0022). Study partners of participants with these features also disproportionately denied memory loss: female (AD-MCI: 60.1% vs. 51.7%, P=0.0002; Va-MCI: 70.3% vs. 52.3%, P=0.0011), Black/African American (AD-MCI: 23.5% vs. 11.98%, P<0.0001; Va-MCI: 48.8% vs. 26.5%, P=0.0002), and <16 years of education (AD-MCI only: 33.9% vs. 16.3%, P=0.0262). In AD-MCI and Va-MCI, participants with anxiety were disproportionately represented in the group endorsing memory loss (AD: 28.2% vs. 17.4%, P<0.0001; Va: 31.5% vs. 16.1%, P=0.0071), with analogous results with depression. Conclusion: The findings would suggest extra vigilance in interview-based MCI detection of persons at-risk for self-based or informant-based misreport.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference26 articles.

1. 2018 Alzheimer’s disease facts and figures;Alzheimers Dement,2018

2. Association of short and long sleep duration with amyloid-β burden and cognition in aging;Winer;JAMA Neurol,2021

3. Diagnosing PD‐MCI by MDS task force criteria: how many and which neuropsychological tests?;Goldman;Mov Disord,2015

4. Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: meta‐analysis of diagnostic accuracy studies;Breton;Int J Geriatr Psychiatry,2019

5. Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study;Marshall;Alzheimers Dement,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3